News

American International Biotechnology Services (AIBioTech) has launched its Absolute Match DNA specimen verification test. The test, which is expected to be performed through AIBioTech’s Fairfax Identity Laboratories division,

AkzoNobel has agreed to acquire Penford’s Australian specialty grain wet milling and manufacturing facility in Lane Cove, to boost the supply capability of its National Starch business in

Lexicon Pharmaceuticals (Lexicon) has reported top-line data from its Phase 2 clinical study with LX1031 in patients with non-constipating irritable bowel syndrome (IBS). The results will be presented

Micromeritics has unveiled its Saturn DigiSizer II, a high-definition digital particle size analyzer. The company claims that by utilising a CCD detector containing over three million detector elements,

Merck Serono, a division of Germany-based Merck, has plans to strengthen its global research and development (R&D) capabilities by establishing a global R&D center in Beijing, China. The

Seattle Genetics and Agensys, have reported an expansion of their antibody-drug conjugate (ADC) collaboration. Under the amended agreement, Agensys will pay a $12m fee for exclusive rights to

Bio-Clean has reported that testing of its Clean Kill non-alcohol based hand sanitizer has proved that it can be an effective weapon against the epidemic spread of MRSA

The National Association of Drug Diversion Investigators (NADDI) has reported a new initiative for methamphetamine. The National Precursor Log Exchange (NPLEx) is a multi-state electronic tracking program that

Human Genome Sciences (HGS) and Aegera Therapeutics (Aegera) have reported that HGS has initiated dosing in a Phase 1 clinical trial to evaluate the safety and tolerability of